Counter-Regulatory Renin-Angiotensin System: An Important Line of Research to Understand and Limit the Severity of COVID-19.

Annweiler, Cédric; Cao, Zhijian; Papon, Nicolas; Kovacic, Hervé; Sabatier, Jean-Marc

Annweiler, Cédric; Cao, Zhijian; Papon, Nicolas; Kovacic, Hervé; Sabatier, Jean-Marc.

Annweiler C; Department of Geriatric Medicine and Memory Clinic, Research Center on Autonomy and Longevity, University Hospital, Angers, France.
Cao Z; Laboratoire de Psychologie des Pays de la Loire, LPPL EA 4638, SFR Confluences, University of Angers, France.
Papon N; State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan 430072, China.
Kovacic H; Host-Pathogen Interaction Study Group (GEIHP, EA 3142), UNIV Angers, UNIV Brest, Angers, France.
Sabatier JM; Université Aix-Marseille, Institut de Neuro-physiopathologie (INP), UMR 7051, Faculté de Pharmacie, 27 Bd Jean Moulin, 13385 Marseille Cedex, France.

Infect Disord Drug Targets ; 22(2): e100921196331, 2022.

Article in English | MEDLINE | ID: covidwho-1405377

Subject(s)

COVID-19; Renin-Angiotensin System; Angiotensin-Converting Enzyme 2; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Renin-Angiotensin System / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Infect Disord Drug Targets Journal subject: Communicable Diseases / Drug Therapy Year: 2022 Document Type: Article Affiliation country: 1871526521666210910063227

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google